Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03827473
Title Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer (ACADEMIC)
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Utah

prostate adenocarcinoma


Abiraterone + Prednisone


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.